This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Co-sponsors highlight important research to be presented at the 2013 Breast Cancer Symposium

September 7th, 2013

Five additional studies of note are among those that will be presented at the 2013 Breast Cancer Symposium, taking place September 7-9, 2013 at the San Francisco Marriott Marquis in San Francisco, California. Two studies examine cognitive function in women who undergo treatment for early-stage breast cancer; a third evaluates impact of tumor genotyping on clinical trial enrollment; and the final two evaluate the outcomes of different treatment approaches.

Saturday, September 7 Presentations

Abstract #48:

Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy (NCT) and analysis of survival outcome.

General Poster Session A

Saturday, September 7, 2013, 11:30 AM – 1:00 PM PST

Saturday, September 7, 2013, 4:30 PM – 6:00 PM PST

Golden Gate Hall

Napa Parinyanitikul, MD

The University of Texas MD Anderson Cancer Center

Houston, TX

Abstract # 55:

Ten-year outcomes of accelerated partial breast irradiation compared with whole breast irradiation: A matched-pair analysis.

Poster Discussion A

Saturday, September 7, 2013, 4:00 PM – 4:20 PM PST

Yerba Buena Ballroom, Salon 8

Jessica Wobb, MD

Oakland University William Beaumont School of

Medicine, Beaumont Cancer Institute

Royal Oak, MI

Sunday, September 8 Presentations

Abstract # 105:

Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (BC): Relationship between perceived and measurable cognitive deficits.

Poster Discussion B

Sunday, September 8, 2013, 3:00 PM – 3:20 PM PST

Yerba Buena Ballroom, Salon 8

Lara Heflin, PhD

New Mexico Highlands University

Las Vegas, NM

Abstract # 104:

Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (ESBC): Predictors of cognitive decline.

Poster Discussion B

Sunday, September 8, 2013, 3:00 PM – 3:20 PM PST

Yerba Buena Ballroom, Salon 8

Hope S. Rugo, MD

UCSF Helen Diller Family Comprehensive Cancer Center

San Francisco, CA

Abstract # 145:

Impact of routine tumor genotyping on enrollment in targeted therapy trials for metastatic breast cancer (MBC): 4-year review.

Poster Discussion B

Sunday, September 8, 2013, 4:00 PM – 4:20 PM PST

Yerba Buena Ballroom, Salon 8

Aditya Bardia, MD

Massachusetts General Hospital,

Harvard Medical School

Boston, MA

Provided by American Society of Clinical Oncology

Citation: Co-sponsors highlight important research to be presented at the 2013 Breast Cancer Symposium (2013, September 7) retrieved 29 July 2026 from https://sciencex.com/wire-news/139977379/co-sponsors-highlight-important-research-to-be-presented-at-the.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.